Drug shortage
Sodium Chloride 0.9% Injection · Hospira, Inc., a Pfizer Company
FDA drug shortage · Current · updated Apr 11, 2025
Key facts
| Generic name | Sodium Chloride 0.9% Injection |
|---|---|
| Proprietary name | Sodium Chloride 0.9% In Plastic Container |
| Company | Hospira, Inc., a Pfizer Company |
| Presentation | Sodium Chloride 0.9% In Plastic Container, Injection, 900 mg/100 mL (9%, 9mg/mL) (NDC 0409-7101-67) |
| Dosage form | Injection |
| Strength | 900 mg/100 mL (9%, 9mg/mL) |
| Status | Current |
| Therapeutic category | Gastroenterology Other Pediatric |
| Package NDCs | 0409-7101-67 |
| First posted | Dec 10, 2021 |
| Last updated | Apr 11, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: